Compare ARK Genomic Revolution ETF (ARKG) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Paychex, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Paychex, Inc. trades at $121.15 (market cap $43.14B). The key difference: Paychex, Inc. pays a 3.92% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Paychex, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | PAYX | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.55 | $140.81 |
52-Week Low | $24.02 | $85.57 |
Market Cap | — | $43.14B |
Enterprise Value | — | $46.63B |
Dividend Yield | — | 3.92% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
